share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina

Recursion Pharmaceuticals | 4:持股變動聲明-高管 Marriott Tina
美股SEC公告 ·  09/30 18:18
Moomoo AI 已提取核心訊息
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 6,000 shares of the company's Class A Common Stock on September 26, 2024. The transaction was executed at a price of $7.0008 per share, resulting in a total market value of $42,004.80. Prior to this sale, Marriott acquired the same number of shares at $1.06 each through the exercise of derivative securities. Following the transactions, Marriott's direct holdings in Recursion Pharmaceuticals amount to 521,138 shares.
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 6,000 shares of the company's Class A Common Stock on September 26, 2024. The transaction was executed at a price of $7.0008 per share, resulting in a total market value of $42,004.80. Prior to this sale, Marriott acquired the same number of shares at $1.06 each through the exercise of derivative securities. Following the transactions, Marriott's direct holdings in Recursion Pharmaceuticals amount to 521,138 shares.
Recursion Pharmaceuticals的總裁兼首席運營官Tina Marriott於2024年9月26日完成了對公司A類普通股的6,000股出售交易。每股交易價格爲7.0008美元,總市值爲42,004.80美元。在此次出售之前,Marriott通過行使衍生證券以每股1.06美元的價格獲得了同樣數量的股份。交易完成後,Marriott在Recursion Pharmaceuticals的直接持股達到了521,138股。
Recursion Pharmaceuticals的總裁兼首席運營官Tina Marriott於2024年9月26日完成了對公司A類普通股的6,000股出售交易。每股交易價格爲7.0008美元,總市值爲42,004.80美元。在此次出售之前,Marriott通過行使衍生證券以每股1.06美元的價格獲得了同樣數量的股份。交易完成後,Marriott在Recursion Pharmaceuticals的直接持股達到了521,138股。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息